At Monon Bioventures, we work with scientists and physicians to turn their discoveries into investable assets so they may reach the clinic and, eventually, the marketplace. We are a part of a larger network of early and late stage pharma/biotech startup operators, partners and capital providers. Our collaborators are all across the US with concentration on both east (Boston and NYC) and west (Seattle) coasts. We work hard and move quickly. We take pride in being an excellent partner for scientists and research institutions and have a strong track record of success. If you are a scientist with an interesting pre-clinical or clinical asset that has the potential to meet an unmet medical need, please don't hesitate to reach out to us.

Kylin Therapeutics, Inc. is a biotechnology company developing RNA-based therapeutics. Kylin uses proprietary pRNA technology to enable the use of siRNA, aptamers, and ribozymes as therapeutics for cancer and other diseases.